Berkshire Asset Management LLC Insulet Corp Transaction History

Berkshire Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $9,536 - $11,558	35 Added 4.8%	764 $220,000
Q1 2023 Jun 06, 2023	BUY	$276.36 - $326.03 $201,466 - $237,675	729 New	729 $232,000
Q2 2022 Aug 12, 2022	SELL	$186.4 - $279.02 $23,300 - $34,877	-125 Reduced 11.37%	974 $212,000
Q1 2022 May 16, 2022	BUY	$194.8 - $275.7 $214,085 - $302,994	1,099 New	1,099 $293,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Berkshire Asset Management LLC with notifications on news.